X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DIVIS LABORATORIES - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DIVIS LABORATORIES FULFORD INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 398.8 31.3 1,272.5% View Chart
P/BV x 6.2 5.4 114.5% View Chart
Dividend Yield % 0.1 0.9 9.3%  

Financials

 FULFORD INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DIVIS LABORATORIES
Mar-17
FULFORD INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9421,222 77.1%   
Low Rs450784 57.4%   
Sales per share (Unadj.) Rs691.4153.1 451.6%  
Earnings per share (Unadj.) Rs11.539.9 28.7%  
Cash flow per share (Unadj.) Rs15.444.6 34.4%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.31.0 28.8%  
Book value per share (Unadj.) Rs380.0201.8 188.3%  
Shares outstanding (eoy) m3.90265.47 1.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.06.6 15.4%   
Avg P/E ratio x60.725.1 241.8%  
P/CF ratio (eoy) x45.322.5 201.5%  
Price / Book Value ratio x1.85.0 36.9%  
Dividend payout %17.425.0 69.7%   
Avg Mkt Cap Rs m2,714266,266 1.0%   
No. of employees `0000.49.7 4.6%   
Total wages/salary Rs m5054,687 10.8%   
Avg. sales/employee Rs Th6,073.04,175.0 145.5%   
Avg. wages/employee Rs Th1,137.4481.5 236.2%   
Avg. net profit/employee Rs Th100.71,089.3 9.2%   
INCOME DATA
Net Sales Rs m2,69640,643 6.6%  
Other income Rs m125749 16.7%   
Total revenues Rs m2,82241,392 6.8%   
Gross profit Rs m-4614,460 -0.3%  
Depreciation Rs m151,233 1.2%   
Interest Rs m1023 42.0%   
Profit before tax Rs m5413,953 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m103,349 0.3%   
Profit after tax Rs m4510,604 0.4%  
Gross profit margin %-1.735.6 -4.8%  
Effective tax rate %17.724.0 73.7%   
Net profit margin %1.726.1 6.4%  
BALANCE SHEET DATA
Current assets Rs m1,73840,105 4.3%   
Current liabilities Rs m5456,595 8.3%   
Net working cap to sales %44.382.5 53.7%  
Current ratio x3.26.1 52.5%  
Inventory Days Days48119 40.9%  
Debtors Days Days481 5.3%  
Net fixed assets Rs m1219,995 0.1%   
Share capital Rs m39531 7.3%   
"Free" reserves Rs m1,44353,043 2.7%   
Net worth Rs m1,48253,574 2.8%   
Long term debt Rs m00-   
Total assets Rs m2,07761,585 3.4%  
Interest coverage x6.7618.4 1.1%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.7 196.7%   
Return on assets %2.617.3 15.1%  
Return on equity %3.019.8 15.2%  
Return on capital %4.326.1 16.5%  
Exports to sales %00-   
Imports to sales %24.525.2 96.9%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m65910,259 6.4%   
Fx inflow Rs m1735,384 0.0%   
Fx outflow Rs m67310,399 6.5%   
Net fx Rs m-65624,985 -2.6%   
CASH FLOW
From Operations Rs m9011,493 0.8%  
From Investments Rs m105-11,372 -0.9%  
From Financial Activity Rs m-14-93 15.1%  
Net Cashflow Rs m18128 635.6%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 11.8 32.2%  
FIIs % 0.1 19.0 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.2 123.3%  
Shareholders   4,783 31,796 15.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   SUN PHARMA  DR. REDDYS LAB  NOVARTIS  UNICHEM LAB  MERCK LTD  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - GLENMARK PHARMA COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS